Y. Miao
Research Subjects
Y. Miao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Wladimir Mauhin
Department of Internal Medicine Diaconesses Croix‐Saint Simon Hospital Paris France
2 shared publications A. Colson
1 shared publicationB. Subran
1 shared publicationC. Montagner
1 shared publication- Caroline Robert
Département de Médecine Oncologique, Gustave Roussy, Villejuif, France
1 shared publication E. Routier
Dermatology Service Department of Medicine Gustave Roussy Villejuif France
1 shared publication
Latest Publications
- 2 December 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (S1) , 74-76
Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir‐Torre Syndrome)
Keratoacanthoma (KA) and well‐differentiated cutaneous squamous cell carcinoma (cSCC) are hardly distinguishable clinically and histologically. They both can be seen in patients with hereditary non‐polyposis colorectal cancer (HNPCC) or Lynch Syndrome, corresponding to DNA microsatellite instability. In our case, a young man had the excision of two rapidly growing skin tumours for which distinction between KA and cSCC was initially clinically and pathologically challenging. The diagnosis of well‐differentiated cSCCs was made and the patient was treated with surgery. Ten years after the first cSCC, he was diagnosed with Muir‐Torre syndrome, a variant of Lynch syndrome, with an heterozygote mutation of the MSH2 gene. This later diagnosis allowed to screen his family members for the same mutation and to adopt an appropriate follow‐up regarding the risk of digestive tumours for him and his family. Furthermore, it is important to know that, in case of non‐resectable cSCC occurring in this patient, immunotherapy using anti‐PD1 antibody would probably be effective due to the known increased immunogenicity of MMR deficient tumours.
- 2 December 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (S1) , 74-76
Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir‐Torre Syndrome)
Keratoacanthoma (KA) and well‐differentiated cutaneous squamous cell carcinoma (cSCC) are hardly distinguishable clinically and histologically. They both can be seen in patients with hereditary non‐polyposis colorectal cancer (HNPCC) or Lynch Syndrome, corresponding to DNA microsatellite instability. In our case, a young man had the excision of two rapidly growing skin tumours for which distinction between KA and cSCC was initially clinically and pathologically challenging. The diagnosis of well‐differentiated cSCCs was made and the patient was treated with surgery. Ten years after the first cSCC, he was diagnosed with Muir‐Torre syndrome, a variant of Lynch syndrome, with an heterozygote mutation of the MSH2 gene. This later diagnosis allowed to screen his family members for the same mutation and to adopt an appropriate follow‐up regarding the risk of digestive tumours for him and his family. Furthermore, it is important to know that, in case of non‐resectable cSCC occurring in this patient, immunotherapy using anti‐PD1 antibody would probably be effective due to the known increased immunogenicity of MMR deficient tumours.
- 1 October 2021
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 42 (10) , 729-733
Syndrome multicarentiel catastrophique post bypass gastrique
- 1 October 2021
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 42 (10) , 729-733
Syndrome multicarentiel catastrophique post bypass gastrique
- Open Access
- 3 June 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (8) , e270
First case of acute pancreatitis related to SARS-CoV-2 infection
- 3 June 2020
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (8) , e270
Open AccessFirst case of acute pancreatitis related to SARS-CoV-2 infection